{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:33:20Z","timestamp":1791315200471,"version":"4.3.1"},"reference-count":201,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2024A1515011990"],"award-info":[{"award-number":["2024A1515011990"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2024A1515011990"],"award-info":[{"award-number":["2024A1515011990"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2024A1515011990"],"award-info":[{"award-number":["2024A1515011990"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2024A1515011990"],"award-info":[{"award-number":["2024A1515011990"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2024A1515011990"],"award-info":[{"award-number":["2024A1515011990"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2024A1515011990"],"award-info":[{"award-number":["2024A1515011990"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2024A1515011990"],"award-info":[{"award-number":["2024A1515011990"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2024A1515011990"],"award-info":[{"award-number":["2024A1515011990"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2024A1515011990"],"award-info":[{"award-number":["2024A1515011990"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2025QC1658"],"award-info":[{"award-number":["ZR2025QC1658"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2024NSFSC1591"],"award-info":[{"award-number":["2024NSFSC1591"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04538-4","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:33:31Z","timestamp":1778686411000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tetrahedral framework nucleic acids as a promising vehicle for small molecule drugs of traditional Chinese medicine: application to disease prevention and treatment"],"prefix":"10.1186","volume":"24","author":[{"given":"Lulu","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lechuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanqi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoran","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songhang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"4538_CR1","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1055\/s-0030-1250186","volume":"76","author":"WL Hsiao","year":"2010","unstructured":"Hsiao WL, Liu L. The role of traditional Chinese herbal medicines in cancer therapy\u2013from TCM theory to mechanistic insights. Planta Med. 2010;76:1118\u201331.","journal-title":"Planta Med"},{"key":"4538_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1126\/science.319.5864.709","volume":"319","author":"R Stone","year":"2008","unstructured":"Stone R. Biochemistry. Lifting the veil on traditional Chinese medicine. Science. 2008;319:709\u201310.","journal-title":"Science"},{"key":"4538_CR3","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2015.05.011","volume":"161","author":"J Liu","year":"2015","unstructured":"Liu J, Lee J, Salazar Hernandez MA, Mazitschek R, Ozcan U. Treatment of obesity with celastrol. Cell. 2015;161:999\u20131011.","journal-title":"Cell"},{"key":"4538_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jcjd.2018.07.002","volume":"43","author":"X Zhang","year":"2019","unstructured":"Zhang X, Xue XC, Wang Y, Cao FF, You J, Uzan G, Peng B, Zhang DH. Celastrol Reverses Palmitic Acid-Induced Insulin Resistance in HepG2 Cells via Restoring the miR-223 and GLUT4 Pathway. Can J Diabetes. 2019;43:165\u201372.","journal-title":"Can J Diabetes"},{"key":"4538_CR5","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.2147\/CMAR.S278023","volume":"13","author":"H Si","year":"2021","unstructured":"Si H, Wang H, Xiao H, Fang Y, Wu Z. Anti-Tumor Effect of Celastrol on Hepatocellular Carcinoma by the circ_SLIT3\/miR-223-3p\/CXCR4 Axis. Cancer Manag Res. 2021;13:1099\u2013111.","journal-title":"Cancer Manag Res"},{"key":"4538_CR6","doi-asserted-by":"publisher","first-page":"10290","DOI":"10.7150\/thno.46728","volume":"10","author":"X Chen","year":"2020","unstructured":"Chen X, Zhao Y, Luo W, Chen S, Lin F, Zhang X, Fan S, Shen X, Wang Y, Liang G. Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells. Theranostics. 2020;10:10290\u2013308.","journal-title":"Theranostics"},{"key":"4538_CR7","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00280-019-03900-8","volume":"84","author":"Z Cha","year":"2019","unstructured":"Cha Z, Cheng J, Xiang H, Qin J, He Y, Peng Z, Jia J, Yu H. Celastrol enhances TRAIL-induced apoptosis in human glioblastoma via the death receptor pathway. Cancer Chemother Pharmacol. 2019;84:719\u201328.","journal-title":"Cancer Chemother Pharmacol"},{"key":"4538_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ejphar.2018.10.043","volume":"842","author":"X Li","year":"2019","unstructured":"Li X, Wang H, Ding J, Nie S, Wang L, Zhang L, Ren S. Celastrol strongly inhibits proliferation, migration and cancer stem cell properties through suppression of Pin1 in ovarian cancer cells. Eur J Pharmacol. 2019;842:146\u201356.","journal-title":"Eur J Pharmacol"},{"key":"4538_CR9","doi-asserted-by":"crossref","unstructured":"Kr\u00fcger P, Hartinger R, Djabali K. Navigating Lipodystrophy: Insights from Laminopathies and Beyond. Int J Mol Sci 2024; 25:8020..","DOI":"10.3390\/ijms25158020"},{"key":"4538_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jep.2012.09.005","volume":"144","author":"J Zhang","year":"2012","unstructured":"Zhang J, Li CY, Xu MJ, Wu T, Chu JH, Liu SJ, Ju WZ. Oral bioavailability and gender-related pharmacokinetics of celastrol following administration of pure celastrol and its related tablets in rats. J Ethnopharmacol. 2012;144:195\u2013200.","journal-title":"J Ethnopharmacol"},{"key":"4538_CR11","doi-asserted-by":"publisher","first-page":"e02527","DOI":"10.1016\/j.heliyon.2019.e02527","volume":"5","author":"W Zhao","year":"2019","unstructured":"Zhao W, Xiao L, Pan L, Ke X, Zhang Y, Zhong D, Xu J, Cao F, Wu L, Chen Y. Cardiac toxicity of Triptergium wilfordii Hook F. may correlate with its inhibition to hERG channel. Heliyon. 2019;5:e02527.","journal-title":"Heliyon"},{"key":"4538_CR12","doi-asserted-by":"publisher","first-page":"115090","DOI":"10.1016\/j.jep.2022.115090","volume":"289","author":"M Dai","year":"2022","unstructured":"Dai M, Peng W, Zhang T, Zhao Q, Ma X, Cheng Y, Wang C, Li F. Metabolomics reveals the role of PPAR\u03b1 in Tripterygium Wilfordii-induced liver injury. J Ethnopharmacol. 2022;289:115090.","journal-title":"J Ethnopharmacol"},{"key":"4538_CR13","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3724\/abbs.2022104","volume":"54","author":"Z Chen","year":"2022","unstructured":"Chen Z, Zhuang Z, Meng C, Zhu Z, Zhang Y, Zhang Z. Induction of the ER stress response in NRVMs is linked to cardiotoxicity caused by celastrol. Acta Biochim Biophys Sin (Shanghai). 2022;54:1180\u201392.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"4538_CR14","first-page":"2078","volume":"10","author":"M Wu","year":"2018","unstructured":"Wu M, Chen W, Yu X, Ding D, Zhang W, Hua H, Xu M, Meng X, Zhang X, Zhang Y, et al. Celastrol aggravates LPS-induced inflammation and injuries of liver and kidney in mice. Am J Transl Res. 2018;10:2078\u201386.","journal-title":"Am J Transl Res"},{"key":"4538_CR15","doi-asserted-by":"publisher","first-page":"105572","DOI":"10.1016\/j.phrs.2021.105572","volume":"167","author":"S Xu","year":"2021","unstructured":"Xu S, Feng Y, He W, Xu W, Xu W, Yang H, Li X. Celastrol in metabolic diseases: Progress and application prospects. Pharmacol Res. 2021;167:105572.","journal-title":"Pharmacol Res"},{"key":"4538_CR16","first-page":"2666","volume":"8","author":"TM Kiviharju","year":"2002","unstructured":"Kiviharju TM, Lecane PS, Sellers RG, Peehl DM. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin Cancer Res. 2002;8:2666\u201374.","journal-title":"Clin Cancer Res"},{"key":"4538_CR17","doi-asserted-by":"publisher","first-page":"e2003451","DOI":"10.1002\/smll.202003451","volume":"16","author":"X Xie","year":"2020","unstructured":"Xie X, Zhan C, Wang J, Zeng F, Wu S. An Activatable Nano-Prodrug for Treating Tyrosine-Kinase-Inhibitor-Resistant Non-Small Cell Lung Cancer and for Optoacoustic and Fluorescent Imaging. Small. 2020;16:e2003451.","journal-title":"Small"},{"key":"4538_CR18","doi-asserted-by":"crossref","unstructured":"Wang C, Liu B, Xu X, Zhuang B, Li H, Yin J, Cong M, Xu W, Lu A. Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine. Oncotarget. 2016;7:8360\u20138372.","DOI":"10.18632\/oncotarget.7073"},{"key":"4538_CR19","doi-asserted-by":"publisher","first-page":"1137289","DOI":"10.3389\/fphar.2024.1137289","volume":"15","author":"Y Sun","year":"2024","unstructured":"Sun Y, Wang C, Li X, Lu J, Wang M. Recent advances in drug delivery of celastrol for enhancing efficiency and reducing the toxicity. Front Pharmacol. 2024;15:1137289.","journal-title":"Front Pharmacol"},{"key":"4538_CR20","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1021\/acs.molpharmaceut.9b00428","volume":"17","author":"X Chen","year":"2020","unstructured":"Chen X, Hu X, Hu J, Qiu Z, Yuan M, Zheng G. Celastrol-Loaded Galactosylated Liposomes Effectively Inhibit AKT\/c-Met-Triggered Rapid Hepatocarcinogenesis in Mice. Mol Pharm. 2020;17:738\u201347.","journal-title":"Mol Pharm"},{"key":"4538_CR21","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41467-017-00834-8","volume":"8","author":"L Guo","year":"2017","unstructured":"Guo L, Luo S, Du Z, Zhou M, Li P, Fu Y, Sun X, Huang Y, Zhang Z. Targeted delivery of celastrol to mesangial cells is effective against mesangioproliferative glomerulonephritis. Nat Commun. 2017;8:878.","journal-title":"Nat Commun"},{"key":"4538_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.apsb.2018.12.009","volume":"9","author":"X Cao","year":"2019","unstructured":"Cao X, Hu Y, Luo S, Wang Y, Gong T, Sun X, Fu Y, Zhang Z. Neutrophil-mimicking therapeutic nanoparticles for targeted chemotherapy of pancreatic carcinoma. Acta Pharm Sin B. 2019;9:575\u201389.","journal-title":"Acta Pharm Sin B"},{"key":"4538_CR23","first-page":"1013","volume":"45","author":"Y Ye","year":"2025","unstructured":"Ye Y, Yu B, Lu S, Zhou Y, Ding M, Cheng G. [Design and inflammation-targeting efficiency assessment of an engineered liposome-based nanomedicine delivery system targeting E-selectin]. Nan Fang Yi Ke Da Xue Xue Bao. 2025;45:1013\u201322.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"4538_CR24","doi-asserted-by":"publisher","first-page":"102757","DOI":"10.1016\/j.cis.2022.102757","volume":"309","author":"M Dymek","year":"2022","unstructured":"Dymek M, Sikora E. Liposomes as biocompatible and smart delivery systems - the current state. Adv Colloid Interface Sci. 2022;309:102757.","journal-title":"Adv Colloid Interface Sci"},{"key":"4538_CR25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jconrel.2021.12.033","volume":"342","author":"C Stavnsbjerg","year":"2022","unstructured":"Stavnsbjerg C, Christensen E, M\u00fcnter R, Henriksen JR, Fach M, Parhamifar L, Christensen C, Kjaer A, Hansen AE. Andresen TL: Accelerated blood clearance and hypersensitivity by PEGylated liposomes containing TLR agonists. J Control Release. 2022;342:337\u201344.","journal-title":"J Control Release"},{"key":"4538_CR26","doi-asserted-by":"publisher","first-page":"113851","DOI":"10.1016\/j.addr.2021.113851","volume":"176","author":"DE Large","year":"2021","unstructured":"Large DE, Abdelmessih RG, Fink EA, Auguste DT. Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv Drug Deliv Rev. 2021;176:113851.","journal-title":"Adv Drug Deliv Rev"},{"key":"4538_CR27","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1021\/acs.molpharmaceut.4c00995","volume":"22","author":"Z Song","year":"2025","unstructured":"Song Z, Jin L, Jiao L, Yu R, Liu H, Zhang S, Hu Y, Sun Y, Li E, Zhao G, et al. ALC-0315 Lipid-Based mRNA LNP Induces Stronger Cellular Immune Responses Postvaccination. Mol Pharm. 2025;22:859\u201370.","journal-title":"Mol Pharm"},{"key":"4538_CR28","doi-asserted-by":"publisher","first-page":"114857","DOI":"10.1016\/j.addr.2023.114857","volume":"198","author":"B Wan","year":"2023","unstructured":"Wan B, Bao Q, Burgess D. Long-acting PLGA microspheres: Advances in excipient and product analysis toward improved product understanding. Adv Drug Deliv Rev. 2023;198:114857.","journal-title":"Adv Drug Deliv Rev"},{"key":"4538_CR29","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.1021\/acsbiomaterials.0c01228","volume":"6","author":"J Yoo","year":"2020","unstructured":"Yoo J, Won YY. Phenomenology of the Initial Burst Release of Drugs from PLGA Microparticles. ACS Biomater Sci Eng. 2020;6:6053\u201362.","journal-title":"ACS Biomater Sci Eng"},{"key":"4538_CR30","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1080\/10717544.2021.1938756","volume":"28","author":"Y Su","year":"2021","unstructured":"Su Y, Zhang B, Sun R, Liu W, Zhu Q, Zhang X, Wang R, Chen C. PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application. Drug Deliv. 2021;28:1397\u2013418.","journal-title":"Drug Deliv"},{"key":"4538_CR31","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1080\/03601234.2019.1634971","volume":"54","author":"Q Wang","year":"2019","unstructured":"Wang Q, Shen M, Li W, Li W, Zhang F. Controlled-release of fluazinam from biodegradable PLGA-based microspheres. J Environ Sci Health B. 2019;54:810\u20136.","journal-title":"J Environ Sci Health B"},{"key":"4538_CR32","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41392-023-01654-7","volume":"8","author":"B Xu","year":"2023","unstructured":"Xu B, Li S, Shi R, Liu H. Multifunctional mesoporous silica nanoparticles for biomedical applications. Signal Transduct Target Ther. 2023;8:435.","journal-title":"Signal Transduct Target Ther"},{"key":"4538_CR33","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.biopha.2018.10.167","volume":"109","author":"S Jafari","year":"2019","unstructured":"Jafari S, Derakhshankhah H, Alaei L, Fattahi A, Varnamkhasti BS. Saboury AA: Mesoporous silica nanoparticles for therapeutic\/diagnostic applications. Biomed Pharmacother. 2019;109:1100\u201311.","journal-title":"Biomed Pharmacother"},{"key":"4538_CR34","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2174\/1567201813666151202195104","volume":"13","author":"MA Chowdhury","year":"2016","unstructured":"Chowdhury MA. The Controlled Release of Drugs and Bioactive Compounds from Mesoporous Silica Nanoparticles. Curr Drug Deliv. 2016;13:839\u201356.","journal-title":"Curr Drug Deliv"},{"key":"4538_CR35","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1039\/c3cs35405a","volume":"42","author":"SH Wu","year":"2013","unstructured":"Wu SH, Mou CY, Lin HP. Synthesis of mesoporous silica nanoparticles. Chem Soc Rev. 2013;42:3862\u201375.","journal-title":"Chem Soc Rev"},{"key":"4538_CR36","doi-asserted-by":"publisher","first-page":"114068","DOI":"10.1016\/j.jconrel.2025.114068","volume":"386","author":"KM Dave","year":"2025","unstructured":"Dave KM, Pinky, PP, D SM. Molecular engineering of extracellular vesicles for drug delivery: Strategies, challenges, and perspectives. J Control Release. 2025;386:114068.","journal-title":"J Control Release"},{"key":"4538_CR37","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s11095-025-03961-w","volume":"42","author":"SR Mendonca","year":"2025","unstructured":"Mendonca SR, Bangera PD, Keerikkadu M, Tippavajhala VK, Rathnanand M. Multifunctional Engineering of Exosomes for Precision Therapeutics: Strategies for Targeted Delivery, Barrier Evasion, and Clinical Translation. Pharm Res. 2025;42:1931\u201352.","journal-title":"Pharm Res"},{"key":"4538_CR38","doi-asserted-by":"publisher","first-page":"115461","DOI":"10.1016\/j.addr.2024.115461","volume":"215","author":"J Bader","year":"2024","unstructured":"Bader J, Brigger F, Leroux JC. Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids. Adv Drug Deliv Rev. 2024;215:115461.","journal-title":"Adv Drug Deliv Rev"},{"key":"4538_CR39","doi-asserted-by":"publisher","first-page":"e13678","DOI":"10.1111\/cpr.13678","volume":"57","author":"Y Liu","year":"2024","unstructured":"Liu Y, Li K, Zhuang W, Liang L, Chen X, Yu D. Tetrahedral framework nucleic acid-based small-molecule inhibitor delivery for ecological prevention of biofilm. Cell Prolif. 2024;57:e13678.","journal-title":"Cell Prolif"},{"key":"4538_CR40","doi-asserted-by":"publisher","first-page":"e2104359","DOI":"10.1002\/smll.202104359","volume":"17","author":"S Li","year":"2021","unstructured":"Li S, Liu Y, Tian T, Zhang T, Lin S, Zhou M, Zhang X, Lin Y. Cai X: Bioswitchable Delivery of microRNA by Framework Nucleic Acids: Application to Bone Regeneration. Small. 2021;17:e2104359.","journal-title":"Small"},{"key":"4538_CR41","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41392-021-00727-9","volume":"6","author":"W Ma","year":"2021","unstructured":"Ma W, Zhan Y, Zhang Y, Mao C, Xie X, Lin Y. The biological applications of DNA nanomaterials: current challenges and future directions. Signal Transduct Target Ther. 2021;6:351.","journal-title":"Signal Transduct Target Ther"},{"key":"4538_CR42","doi-asserted-by":"publisher","first-page":"e2107820","DOI":"10.1002\/adma.202107820","volume":"34","author":"T Zhang","year":"2022","unstructured":"Zhang T, Tian T, Lin Y. Functionalizing Framework Nucleic-Acid-Based Nanostructures for Biomedical Application. Adv Mater. 2022;34:e2107820.","journal-title":"Adv Mater"},{"key":"4538_CR43","first-page":"74","volume":"12","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xie X, Ma W, Zhan Y, Mao C, Shao X, Lin Y. Multi-targeted Antisense Oligonucleotide Delivery by a Framework Nucleic Acid for Inhibiting Biofilm Formation and Virulence. Nanomicro Lett. 2020;12:74.","journal-title":"Nanomicro Lett"},{"key":"4538_CR44","doi-asserted-by":"publisher","first-page":"e2410162","DOI":"10.1002\/smll.202410162","volume":"21","author":"Z Yang","year":"2025","unstructured":"Yang Z, Shi L, Wang Y, Zhou D, Zhang C, Lin Y. Unveiling the Potential of Tetrahedral DNA Frameworks in Clinical Medicine: Mechanisms, Advances, and Future Perspectives. Small. 2025;21:e2410162.","journal-title":"Small"},{"key":"4538_CR45","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41467-020-20638-7","volume":"12","author":"S Zhao","year":"2021","unstructured":"Zhao S, Tian R, Wu J, Liu S, Wang Y, Wen M, Shang Y, Liu Q, Li Y, Guo Y, et al. A DNA origami-based aptamer nanoarray for potent and reversible anticoagulation in hemodialysis. Nat Commun. 2021;12:358.","journal-title":"Nat Commun"},{"key":"4538_CR46","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nature06597","volume":"452","author":"Y He","year":"2008","unstructured":"He Y, Ye T, Su M, Zhang C, Ribbe AE, Jiang W, Mao C. Hierarchical self-assembly of DNA into symmetric supramolecular polyhedra. Nature. 2008;452:198\u2013201.","journal-title":"Nature"},{"key":"4538_CR47","first-page":"279","volume":"33","author":"W Wang","year":"2024","unstructured":"Wang W, Lin M, Wang W, Shen Z, Wu ZS. DNA tetrahedral nanostructures for the biomedical application and spatial orientation of biomolecules. Bioact Mater. 2024;33:279\u2013310.","journal-title":"Bioact Mater"},{"key":"4538_CR48","doi-asserted-by":"publisher","first-page":"8783","DOI":"10.1021\/nn202774x","volume":"5","author":"J Li","year":"2011","unstructured":"Li J, Pei H, Zhu B, Liang L, Wei M, He Y, Chen N, Li D, Huang Q, Fan C. Self-assembled multivalent DNA nanostructures for noninvasive intracellular delivery of immunostimulatory CpG oligonucleotides. ACS Nano. 2011;5:8783\u20139.","journal-title":"ACS Nano"},{"key":"4538_CR49","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.1021\/nn2005574","volume":"5","author":"AS Walsh","year":"2011","unstructured":"Walsh AS, Yin H, Erben CM, Wood MJ. Turberfield AJ: DNA cage delivery to mammalian cells. ACS Nano. 2011;5:5427\u201332.","journal-title":"ACS Nano"},{"key":"4538_CR50","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41596-024-01050-7","volume":"20","author":"S Li","year":"2025","unstructured":"Li S, Tian T, Zhang T, Lin Y, Cai X. A bioswitchable delivery system for microRNA therapeutics based on a tetrahedral DNA nanostructure. Nat Protoc. 2025;20:336\u201362.","journal-title":"Nat Protoc"},{"key":"4538_CR51","doi-asserted-by":"publisher","first-page":"e2406118","DOI":"10.1002\/adma.202406118","volume":"36","author":"X Chen","year":"2024","unstructured":"Chen X, Xu Z, Gao Y, Chen Y, Yin W, Liu Z, Cui W, Li Y, Sun J, Yang Y, et al. Framework Nucleic Acid-Based Selective Cell Catcher for Endogenous Stem Cell Recruitment. Adv Mater. 2024;36:e2406118.","journal-title":"Adv Mater"},{"key":"4538_CR52","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1021\/acs.nanolett.0c00529","volume":"20","author":"Y Liu","year":"2020","unstructured":"Liu Y, Sun Y, Li S, Liu M, Qin X, Chen X, Lin Y. Tetrahedral Framework Nucleic Acids Deliver Antimicrobial Peptides with Improved Effects and Less Susceptibility to Bacterial Degradation. Nano Lett. 2020;20:3602\u201310.","journal-title":"Nano Lett"},{"key":"4538_CR53","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/1389200224666230413082047","volume":"24","author":"H Huang","year":"2023","unstructured":"Huang H, Gao S, Cai X. DNA-based Nanomaterials in the Immunotherapy. Curr Drug Metab. 2023;24:367\u201384.","journal-title":"Curr Drug Metab"},{"key":"4538_CR54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jconrel.2023.10.022","volume":"364","author":"B Tang","year":"2023","unstructured":"Tang B, Ma W, Lin Y. Emerging applications of anti-angiogenic nanomaterials in oncotherapy. J Control Release. 2023;364:61\u201378.","journal-title":"J Control Release"},{"key":"4538_CR55","doi-asserted-by":"crossref","unstructured":"Liu Y, Zeng C, Huang Z, Zhuang W, Chen X, Li S, Liu Z, Cai Z, Zhu J, Lin Y. A celastrol-loaded DNA nano-patroller regulates hypothalamus leptin sensitivity and adipose energy expenditure for anti-obesity therapy. Chem Eng J 2024;486:150419.","DOI":"10.1016\/j.cej.2024.150419"},{"key":"4538_CR56","doi-asserted-by":"publisher","first-page":"20667","DOI":"10.1039\/C9NR07171G","volume":"11","author":"X Qin","year":"2019","unstructured":"Qin X, Li N, Zhang M, Lin S, Zhu J, Xiao D, Cui W, Zhang T, Lin Y, Cai X. Tetrahedral framework nucleic acids prevent retina ischemia-reperfusion injury from oxidative stress via activating the Akt\/Nrf2 pathway. Nanoscale. 2019;11:20667\u201375.","journal-title":"Nanoscale"},{"key":"4538_CR57","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1021\/acsami.7b17928","volume":"10","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Lin S, Shi S, Zhang T, Ma Q, Tian T, Zhou T, Cai X, Lin Y. Anti-inflammatory and Antioxidative Effects of Tetrahedral DNA Nanostructures via the Modulation of Macrophage Responses. ACS Appl Mater Interfaces. 2018;10:3421\u201330.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4538_CR58","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41368-022-00171-7","volume":"14","author":"D Zhao","year":"2022","unstructured":"Zhao D, Xiao D, Liu M, Li J, Peng S, He Q, Sun Y, Xiao J, Lin Y. Tetrahedral framework nucleic acid carrying angiogenic peptide prevents bisphosphonate-related osteonecrosis of the jaw by promoting angiogenesis. Int J Oral Sci. 2022;14:23.","journal-title":"Int J Oral Sci"},{"key":"4538_CR59","doi-asserted-by":"publisher","first-page":"12733","DOI":"10.1021\/acsami.6b03786","volume":"8","author":"Q Peng","year":"2016","unstructured":"Peng Q, Shao XR, Xie J, Shi SR, Wei XQ, Zhang T, Cai XX, Lin YF. Understanding the Biomedical Effects of the Self-Assembled Tetrahedral DNA Nanostructure on Living Cells. ACS Appl Mater Interfaces. 2016;8:12733\u20139.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4538_CR60","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41392-020-0173-3","volume":"5","author":"J Zhu","year":"2020","unstructured":"Zhu J, Zhang M, Gao Y, Qin X, Zhang T, Cui W, Mao C, Xiao D, Lin Y. Tetrahedral framework nucleic acids promote scarless healing of cutaneous wounds via the AKT-signaling pathway. Signal Transduct Target Ther. 2020;5:120.","journal-title":"Signal Transduct Target Ther"},{"key":"4538_CR61","doi-asserted-by":"publisher","first-page":"19353","DOI":"10.1021\/acsami.6b06528","volume":"8","author":"S Shi","year":"2016","unstructured":"Shi S, Peng Q, Shao X, Xie J, Lin S, Zhang T, Li Q, Li X, Lin Y. Self-Assembled Tetrahedral DNA Nanostructures Promote Adipose-Derived Stem Cell Migration via lncRNA XLOC 010623 and RHOA\/ROCK2 Signal Pathway. ACS Appl Mater Interfaces. 2016;8:19353\u201363.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4538_CR62","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.nano.2018.02.004","volume":"14","author":"M Zhou","year":"2018","unstructured":"Zhou M, Liu NX, Shi SR, Li Y, Zhang Q, Ma QQ, Tian TR, Ma WJ, Cai XX, Lin YF. Effect of tetrahedral DNA nanostructures on proliferation and osteo\/odontogenic differentiation of dental pulp stem cells via activation of the notch signaling pathway. Nanomedicine. 2018;14:1227\u201336.","journal-title":"Nanomedicine"},{"key":"4538_CR63","doi-asserted-by":"publisher","first-page":"37478","DOI":"10.1021\/acsami.2c10364","volume":"14","author":"M Zhou","year":"2022","unstructured":"Zhou M, Zhang T, Zhang X, Zhang M, Gao S, Zhang T, Li S, Cai X, Li J, Lin Y. Effect of Tetrahedral Framework Nucleic Acids on Neurological Recovery via Ameliorating Apoptosis and Regulating the Activation and Polarization of Astrocytes in Ischemic Stroke. ACS Appl Mater Interfaces. 2022;14:37478\u201392.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4538_CR64","doi-asserted-by":"publisher","first-page":"114488","DOI":"10.1016\/j.jconrel.2025.114488","volume":"389","author":"Y Liu","year":"2026","unstructured":"Liu Y, Lin S, Liang L, Cai Z, Zhuang W, Chen X, Gao L, Li S, Lin Y. Bioswitchable intracellular delivery of small activating RNA by tetrahedral framework nucleic acid: Application to p21-mediated anti-tumor therapy. J Control Release. 2026;389:114488.","journal-title":"J Control Release"},{"key":"4538_CR65","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1186\/s12951-024-02963-x","volume":"22","author":"L Tan","year":"2024","unstructured":"Tan L, Xie J, Liao C, Li X, Zhang W, Cai C, Cheng L, Wang X. Tetrahedral framework nucleic acids inhibit A\u03b2-mediated ferroptosis and ameliorate cognitive and synaptic impairments in Alzheimer\u2019s disease. J Nanobiotechnol. 2024;22:682.","journal-title":"J Nanobiotechnol"},{"key":"4538_CR66","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41565-021-00858-8","volume":"16","author":"JJ Rennick","year":"2021","unstructured":"Rennick JJ, Johnston APR, Parton RG. Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics. Nat Nanotechnol. 2021;16:266\u201376.","journal-title":"Nat Nanotechnol"},{"key":"4538_CR67","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/s41401-020-00606-z","volume":"42","author":"SQ Zhang","year":"2021","unstructured":"Zhang SQ, Fu Q, Zhang YJ, Pan JX, Zhang L, Zhang ZR, Liu ZM. Surface loading of nanoparticles on engineered or natural erythrocytes for prolonged circulation time: strategies and applications. Acta Pharmacol Sin. 2021;42:1040\u201354.","journal-title":"Acta Pharmacol Sin"},{"key":"4538_CR68","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jconrel.2016.01.041","volume":"225","author":"Q Peng","year":"2016","unstructured":"Peng Q, Mu H. The potential of protein-nanomaterial interaction for advanced drug delivery. J Control Release. 2016;225:121\u201332.","journal-title":"J Control Release"},{"key":"4538_CR69","doi-asserted-by":"crossref","unstructured":"Zhang T, Zhu G, Lu B, Qian Z, Peng Q. Protein corona formed in the gastrointestinal tract and its impacts on oral delivery of nanoparticles. Med Res Rev 2020;41:1835\u20131850.","DOI":"10.1002\/med.21767"},{"key":"4538_CR70","first-page":"345","volume":"52","author":"YF Lin","year":"2021","unstructured":"Lin YF. Tetrahedral Framework Nucleic Acids and Human Health. Sichuan Da Xue Xue Bao Yi Xue Ban. 2021;52:345\u20139.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"4538_CR71","doi-asserted-by":"publisher","first-page":"e2401360","DOI":"10.1002\/smtd.202401360","volume":"9","author":"Q Fan","year":"2025","unstructured":"Fan Q, Sun B, Chao J. Advancements in Engineering Tetrahedral Framework Nucleic Acids for Biomedical Innovations. Small Methods. 2025;9:e2401360.","journal-title":"Small Methods"},{"key":"4538_CR72","doi-asserted-by":"publisher","first-page":"e2106456","DOI":"10.1002\/adma.202106456","volume":"34","author":"J Li","year":"2022","unstructured":"Li J, Chen C, Xia T. Understanding Nanomaterial-Liver Interactions to Facilitate the Development of Safer Nanoapplications. Adv Mater. 2022;34:e2106456.","journal-title":"Adv Mater"},{"key":"4538_CR73","doi-asserted-by":"publisher","first-page":"e1703393","DOI":"10.1002\/adma.201703393","volume":"30","author":"Z Liu","year":"2018","unstructured":"Liu Z, Li Y, Li W, Xiao C, Liu D, Dong C, Zhang M, M\u00e4kil\u00e4 E, Kemell M, Salonen J, et al. Multifunctional Nanohybrid Based on Porous Silicon Nanoparticles, Gold Nanoparticles, and Acetalated Dextran for Liver Regeneration and Acute Liver Failure Theranostics. Adv Mater. 2018;30:e1703393.","journal-title":"Adv Mater"},{"key":"4538_CR74","doi-asserted-by":"publisher","first-page":"13136","DOI":"10.1021\/acsami.2c02523","volume":"14","author":"Y Chen","year":"2022","unstructured":"Chen Y, Shi S, Li B, Lan T, Yuan K, Yuan J, Zhou Y, Song J, Lv T, Shi Y, et al. Therapeutic Effects of Self-Assembled Tetrahedral Framework Nucleic Acids on Liver Regeneration in Acute Liver Failure. ACS Appl Mater Interfaces. 2022;14:13136\u201346.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4538_CR75","first-page":"50","volume":"28","author":"H Wei","year":"2023","unstructured":"Wei H, Li F, Xue T, Wang H, Ju E, Li M, Tao Y. MicroRNA-122-functionalized DNA tetrahedron stimulate hepatic differentiation of human mesenchymal stem cells for acute liver failure therapy. Bioact Mater. 2023;28:50\u201360.","journal-title":"Bioact Mater"},{"key":"4538_CR76","doi-asserted-by":"publisher","first-page":"10492","DOI":"10.1021\/acsami.2c22579","volume":"15","author":"T Tian","year":"2023","unstructured":"Tian T, Zhao C, Li S, Huang Z, Guo Y, Dai W, Bai R, Tang C, Lin Y, Gao J. Liver-Targeted Delivery of Small Interfering RNA of C-C Chemokine Receptor 2 with Tetrahedral Framework Nucleic Acid Attenuates Liver Cirrhosis. ACS Appl Mater Interfaces. 2023;15:10492\u2013505.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4538_CR77","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41581-024-00819-z","volume":"20","author":"Y Huang","year":"2024","unstructured":"Huang Y, Ning X, Ahrari S, Cai Q, Rajora N, Saxena R, Yu M, Zheng J. Physiological principles underlying the kidney targeting of renal nanomedicines. Nat Rev Nephrol. 2024;20:354\u201370.","journal-title":"Nat Rev Nephrol"},{"key":"4538_CR78","doi-asserted-by":"publisher","first-page":"123237","DOI":"10.1016\/j.biomaterials.2025.123237","volume":"320","author":"Y Ren","year":"2025","unstructured":"Ren Y, Dong Y, Li Z, Xu K, Xu J, Li X, Zhang M, Xu C, Yang M, Lee M, et al. Kidney-targeting DNA tetrahedral molecular cage synergistically inhibits acute kidney injury by clearing ROS and activating HO-1. Biomaterials. 2025;320:123237.","journal-title":"Biomaterials"},{"key":"4538_CR79","doi-asserted-by":"publisher","first-page":"8767","DOI":"10.1021\/acsnano.3c02102","volume":"17","author":"R Yan","year":"2023","unstructured":"Yan R, Cui W, Ma W, Li J, Liu Z, Lin Y. Typhaneoside-Tetrahedral Framework Nucleic Acids System: Mitochondrial Recovery and Antioxidation for Acute Kidney Injury treatment. ACS Nano. 2023;17:8767\u201381.","journal-title":"ACS Nano"},{"key":"4538_CR80","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s12274-019-2271-5","volume":"12","author":"D Jiang","year":"2019","unstructured":"Jiang D, Im HJ, Boleyn ME, England CG, Ni D, Kang L, Engle JW, Huang P, Lan X, Cai W. Efficient renal clearance of DNA tetrahedron nanoparticles enables quantitative evaluation of kidney function. Nano Res. 2019;12:637\u201342.","journal-title":"Nano Res"},{"key":"4538_CR81","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.1021\/acsami.5b10792","volume":"8","author":"D Jiang","year":"2016","unstructured":"Jiang D, Sun Y, Li J, Li Q, Lv M, Zhu B, Tian T, Cheng D, Xia J, Zhang L, et al. Multiple-Armed Tetrahedral DNA Nanostructures for Tumor-Targeting, Dual-Modality in Vivo Imaging. ACS Appl Mater Interfaces. 2016;8:4378\u201384.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4538_CR82","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jconrel.2021.12.034","volume":"342","author":"Y Yang","year":"2022","unstructured":"Yang Y, Zhang X, Wu S, Zhang R, Zhou B, Zhang X, Tang L, Tian Y, Men K, Yang L. Enhanced nose-to-brain delivery of siRNA using hyaluronan-enveloped nanomicelles for glioma therapy. J Control Release. 2022;342:66\u201380.","journal-title":"J Control Release"},{"key":"4538_CR83","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","volume":"37","author":"NJ Abbott","year":"2010","unstructured":"Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010;37:13\u201325.","journal-title":"Neurobiol Dis"},{"key":"4538_CR84","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","volume":"17","author":"H Kadry","year":"2020","unstructured":"Kadry H, Noorani B, Cucullo L. A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020;17:69.","journal-title":"Fluids Barriers CNS"},{"key":"4538_CR85","doi-asserted-by":"publisher","first-page":"782237","DOI":"10.3389\/fbioe.2021.782237","volume":"9","author":"X Chen","year":"2021","unstructured":"Chen X, Xie Y, Liu Z, Lin Y. Application of Programmable Tetrahedral Framework Nucleic Acid-Based Nanomaterials in Neurological Disorders: Progress and Prospects. Front Bioeng Biotechnol. 2021;9:782237.","journal-title":"Front Bioeng Biotechnol"},{"key":"4538_CR86","doi-asserted-by":"publisher","first-page":"44228","DOI":"10.1021\/acsami.2c14626","volume":"14","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhu J, Jia W, Xiong H, Qiu W, Xu R, Lin Y. BACE1 Aptamer-Modified Tetrahedral Framework Nucleic Acid to Treat Alzheimer\u2019s Disease in an APP-PS1 Animal Model. ACS Appl Mater Interfaces. 2022;14:44228\u201338.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4538_CR87","doi-asserted-by":"publisher","first-page":"e12787","DOI":"10.1111\/cpr.12787","volume":"53","author":"X Shao","year":"2020","unstructured":"Shao X, Cui W, Xie X, Ma W, Zhan Y, Lin Y. Treatment of Alzheimer\u2019s disease with framework nucleic acids. Cell Prolif. 2020;53:e12787.","journal-title":"Cell Prolif"},{"key":"4538_CR88","doi-asserted-by":"publisher","first-page":"11925","DOI":"10.1021\/acsami.5c00507","volume":"17","author":"G Du","year":"2025","unstructured":"Du G, Yao Y, Chen W, Lin Y, He Y, Zhou M, Cai X. Tetrahedral Framework Nucleic Acid-Based Delivery System for miRNA-124 and Stroke-Homing Peptide: Targeted Therapy for Acute Ischemic Stroke. ACS Appl Mater Interfaces. 2025;17:11925\u201336.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4538_CR89","doi-asserted-by":"publisher","first-page":"40354","DOI":"10.1021\/acsami.1c11468","volume":"13","author":"Y Li","year":"2021","unstructured":"Li Y, Tang Y, Shi S, Gao S, Wang Y, Xiao D, Chen T, He Q, Zhang J, Lin Y. Tetrahedral Framework Nucleic Acids Ameliorate Insulin Resistance in Type 2 Diabetes Mellitus via the PI3K\/Akt Pathway. ACS Appl Mater Interfaces. 2021;13:40354\u201364.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4538_CR90","doi-asserted-by":"publisher","first-page":"42543","DOI":"10.1021\/acsami.1c14861","volume":"13","author":"S Gao","year":"2021","unstructured":"Gao S, Wang Y, Li Y, Xiao D, Lin Y, Chen Y, Cai X. Tetrahedral Framework Nucleic Acids Reestablish Immune Tolerance and Restore Saliva Secretion in a Sj\u00f6gren\u2019s Syndrome Mouse Model. ACS Appl Mater Interfaces. 2021;13:42543\u201353.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4538_CR91","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1055\/s-0034-1375574","volume":"18","author":"N Egund","year":"2014","unstructured":"Egund N, Jurik AG. Anatomy and histology of the sacroiliac joints. Semin Musculoskelet Radiol. 2014;18:332\u20139.","journal-title":"Semin Musculoskelet Radiol"},{"key":"4538_CR92","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrrheum.2013.159","volume":"10","author":"CH Evans","year":"2014","unstructured":"Evans CH, Kraus VB, Setton LA. Progress in intra-articular therapy. Nat Rev Rheumatol. 2014;10:11\u201322.","journal-title":"Nat Rev Rheumatol"},{"key":"4538_CR93","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1113\/expphysiol.1984.sp002805","volume":"69","author":"AD Knight","year":"1984","unstructured":"Knight AD, Levick JR. Morphometry of the ultrastructure of the blood-joint barrier in the rabbit knee. Q J Exp Physiol. 1984;69:271\u201388.","journal-title":"Q J Exp Physiol"},{"key":"4538_CR94","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1002\/jps.21346","volume":"97","author":"C Larsen","year":"2008","unstructured":"Larsen C, Ostergaard J, Larsen SW, Jensen H, Jacobsen S, Lindegaard C, Andersen PH. Intra-articular depot formulation principles: role in the management of postoperative pain and arthritic disorders. J Pharm Sci. 2008;97:4622\u201354.","journal-title":"J Pharm Sci"},{"key":"4538_CR95","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.2147\/IJN.S444347","volume":"19","author":"C Wen","year":"2024","unstructured":"Wen C, Xu X, Zhang Y, Xia J, Liang Y, Xu L. Bone Targeting Nanoparticles for the Treatment of Osteoporosis. Int J Nanomed. 2024;19:1363\u201383.","journal-title":"Int J Nanomed"},{"key":"4538_CR96","doi-asserted-by":"crossref","unstructured":"Shao X, Lin S, Peng Q, Shi S, Wei X, Zhang T, Lin Y. Tetrahedral DNA Nanostructure: A Potential Promoter for Cartilage Tissue Regeneration via Regulating Chondrocyte Phenotype and Proliferation. Small 2017;13:1602770.","DOI":"10.1002\/smll.201602770"},{"key":"4538_CR97","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41413-019-0077-4","volume":"8","author":"S Sirong","year":"2020","unstructured":"Sirong S, Yang C, Taoran T, Songhang L, Shiyu L, Yuxin Z, Xiaoru S, Tao Z, Yunfeng L, Xiaoxiao C. Effects of tetrahedral framework nucleic acid\/wogonin complexes on osteoarthritis. Bone Res. 2020;8:6.","journal-title":"Bone Res"},{"key":"4538_CR98","doi-asserted-by":"publisher","first-page":"e202301147","DOI":"10.1002\/anie.202301147","volume":"62","author":"F Shen","year":"2023","unstructured":"Shen F, Xiong Z, Wu Y, Peng R, Wang Y, Sun L, Fan C, Liu Z. Precise Epitope Organization with Self-adjuvant Framework Nucleic Acid for Efficient COVID-19 Peptide Vaccine Construction. Angew Chem Int Ed Engl. 2023;62:e202301147.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4538_CR99","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1039\/D0QM00329H","volume":"4","author":"Y Gao","year":"2020","unstructured":"Gao Y, Zhang T, Zhu J, Xiao D, Zhang M, Sun Y, Li Y, Lin Y, Cai X. Effects of the tetrahedral framework nucleic acids on the skeletal muscle regeneration in vitro and in vivo. Mater Chem Front. 2020;4:2731\u201343.","journal-title":"Mater Chem Front"},{"key":"4538_CR100","doi-asserted-by":"publisher","first-page":"8816","DOI":"10.1021\/acs.nanolett.3c01502","volume":"23","author":"X Yu","year":"2023","unstructured":"Yu X, Wang Y, Ran L, Jiang Y, Chen M, Du H, Zhang Y, Wu D, Xiang X, Zhang J, et al. Tetrahedral Framework Nucleic Acids Inhibit Muscular Mitochondria-Mediated Apoptosis and Ameliorate Muscle Atrophy in Sarcopenia. Nano Lett. 2023;23:8816\u201326.","journal-title":"Nano Lett"},{"key":"4538_CR101","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.1021\/nl301877k","volume":"12","author":"X Liu","year":"2012","unstructured":"Liu X, Xu Y, Yu T, Clifford C, Liu Y, Yan H, Chang Y. A DNA nanostructure platform for directed assembly of synthetic vaccines. Nano Lett. 2012;12:4254\u20139.","journal-title":"Nano Lett"},{"key":"4538_CR102","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1021\/acs.langmuir.8b02007","volume":"35","author":"A Shchelokov","year":"2019","unstructured":"Shchelokov A, Palko N, Potemkin V, Grishina M, Morozov R, Korina E, Uchaev D. Krivtsov I,Bol\u2019shakov O: Adsorption of Native Amino Acids on Nanocrystalline TiO(2): Physical Chemistry, QSPR, and Theoretical Modeling. Langmuir. 2019;35:538\u201350.","journal-title":"Langmuir"},{"key":"4538_CR103","doi-asserted-by":"crossref","unstructured":"Rancan F, Volkmann H, Giulbudagian M, Schumacher F, Stanko JI, Kleuser B, Blume-Peytavi U. Calder\u00f3n M,Vogt A: Dermal Delivery of the High-Molecular-Weight Drug Tacrolimus by Means of Polyglycerol-Based Nanogels. Pharmaceutics 2019;11:394.","DOI":"10.3390\/pharmaceutics11080394"},{"key":"4538_CR104","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4161\/derm.1.4.9501","volume":"1","author":"M Schneider","year":"2009","unstructured":"Schneider M, Stracke F, Hansen S, Schaefer UF. Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinol. 2009;1:197\u2013206.","journal-title":"Dermatoendocrinol"},{"key":"4538_CR105","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cbi.2017.06.018","volume":"295","author":"K Niska","year":"2018","unstructured":"Niska K, Zielinska E, Radomski MW, Inkielewicz-Stepniak I. Metal nanoparticles in dermatology and cosmetology: Interactions with human skin cells. Chem Biol Interact. 2018;295:38\u201351.","journal-title":"Chem Biol Interact"},{"key":"4538_CR106","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/s41467-019-09029-9","volume":"10","author":"C Wiraja","year":"2019","unstructured":"Wiraja C, Zhu Y, Lio DCS, Yeo DC, Xie M, Fang W, Li Q, Zheng M, Van Steensel M, Wang L, et al. Framework nucleic acids as programmable carrier for transdermal drug delivery. Nat Commun. 2019;10:1147.","journal-title":"Nat Commun"},{"key":"4538_CR107","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/febs.16330","volume":"290","author":"F O\u2019Leary","year":"2023","unstructured":"O\u2019Leary F, Campbell M. The blood-retina barrier in health and disease. Febs j. 2023;290:878\u201391.","journal-title":"Febs j"},{"key":"4538_CR108","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3341\/kjo.2023.0133","volume":"38","author":"KH Lee","year":"2024","unstructured":"Lee KH, Lee SC, Lee MW. Vitreous Opacity Following Intravitreal Brolucizumab Injection: A Case Series Review. Korean J Ophthalmol. 2024;38:113\u201321.","journal-title":"Korean J Ophthalmol"},{"key":"4538_CR109","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1021\/acsami.2c18042","volume":"15","author":"R Wang","year":"2023","unstructured":"Wang R, Liu Y, Xiao W, Yi Q, Jiang M, Guo R, Song L, Li M, Li F, Shi D, et al. Framework Nucleic Acids as Blood-Retinal-Barrier-Penetrable Nanocarrier for Periocular Administration. ACS Appl Mater Interfaces. 2023;15:541\u201351.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4538_CR110","doi-asserted-by":"crossref","unstructured":"Jin Y, Zhou X, Chen L, Xu X, Yan W, Wang Q, Lin Y. Ding X: Framework Nucleic Acids Loaded with Quercetin: Protecting Retinal Neurovascular Unit via the Protein Kinase B\/Heme Oxygenase-1 Pathway. ACS Nano; 2024.","DOI":"10.1021\/acsnano.4c05845"},{"key":"4538_CR111","doi-asserted-by":"publisher","first-page":"e13695","DOI":"10.1111\/cpr.13695","volume":"57","author":"X Xu","year":"2024","unstructured":"Xu X, Fu Y, Luo D, Zhang L, Huang X, Chen Y, Lei C, Liu J, Li S, Yu Z, et al. Therapeutic effects of tetrahedral framework nucleic acids and tFNAs-miR22 on retinal ischemia\/reperfusion injury. Cell Prolif. 2024;57:e13695.","journal-title":"Cell Prolif"},{"key":"4538_CR112","doi-asserted-by":"publisher","first-page":"e13635","DOI":"10.1111\/cpr.13635","volume":"57","author":"Q Wu","year":"2024","unstructured":"Wu Q, Zhu J, Zhang X, Xu X, Luo D, Lin Y, Yan M, Song Y. The antioxidant effect of tetrahedral framework nucleic acid-based delivery of small activating RNA targeting DJ-1 on retinal oxidative stress injury. Cell Prolif. 2024;57:e13635.","journal-title":"Cell Prolif"},{"key":"4538_CR113","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1021\/acsnano.0c08905","volume":"15","author":"T Kim","year":"2021","unstructured":"Kim T, Nam K, Kim YM, Yang K, Roh YH. DNA-Assisted Smart Nanocarriers: Progress, Challenges, and Opportunities. ACS Nano. 2021;15:1942\u201351.","journal-title":"ACS Nano"},{"key":"4538_CR114","doi-asserted-by":"publisher","first-page":"8424","DOI":"10.1039\/D1TB01022K","volume":"9","author":"J Yu","year":"2021","unstructured":"Yu J, Zhang J, Jin J, Jiang W. Microenvironment-responsive DNA-conjugated albumin nanocarriers for targeted therapy. J Mater Chem B. 2021;9:8424\u201336.","journal-title":"J Mater Chem B"},{"key":"4538_CR115","doi-asserted-by":"publisher","first-page":"11561","DOI":"10.1073\/pnas.95.20.11561","volume":"95","author":"SM Zeman","year":"1998","unstructured":"Zeman SM, Phillips DR, Crothers DM. Characterization of covalent adriamycin-DNA adducts. Proc Natl Acad Sci U S A. 1998;95:11561\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4538_CR116","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1021\/acs.chemrev.7b00663","volume":"119","author":"Q Hu","year":"2019","unstructured":"Hu Q, Li H, Wang L, Gu H. Fan C: DNA Nanotechnology-Enabled Drug Delivery Systems. Chem Rev. 2019;119:6459\u2013506.","journal-title":"Chem Rev"},{"key":"4538_CR117","doi-asserted-by":"publisher","first-page":"5690","DOI":"10.1021\/acs.jmedchem.1c02209","volume":"65","author":"H Obata","year":"2022","unstructured":"Obata H, Tsuji AB, Kumata K, Sudo H, Minegishi K, Nagatsu K, Takakura H, Ogawa M, Kurimasa A, Zhang MR. Development of Novel (191)Pt-Labeled Hoechst33258: (191)Pt Is More Suitable than (111)In for Targeting DNA. J Med Chem. 2022;65:5690\u2013700.","journal-title":"J Med Chem"},{"key":"4538_CR118","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2019.02.003","volume":"147","author":"Q Jiang","year":"2019","unstructured":"Jiang Q, Zhao S, Liu J, Song L, Wang ZG. Ding B: Rationally designed DNA-based nanocarriers. Adv Drug Deliv Rev. 2019;147:2\u201321.","journal-title":"Adv Drug Deliv Rev"},{"key":"4538_CR119","doi-asserted-by":"publisher","first-page":"115610","DOI":"10.1016\/j.addr.2025.115610","volume":"223","author":"S Li","year":"2025","unstructured":"Li S, Xu M, Yao C, Yang D. DNA-Based nanostructures for tumor microenvironment-responsive drug delivery. Adv Drug Deliv Rev. 2025;223:115610.","journal-title":"Adv Drug Deliv Rev"},{"key":"4538_CR120","first-page":"368","volume":"8","author":"M Zhang","year":"2022","unstructured":"Zhang M, Zhang X, Tian T, Zhang Q, Wen Y, Zhu J, Xiao D, Cui W, Lin Y. Anti-inflammatory activity of curcumin-loaded tetrahedral framework nucleic acids on acute gouty arthritis. Bioact Mater. 2022;8:368\u201380.","journal-title":"Bioact Mater"},{"key":"4538_CR121","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1039\/D1NA00753J","volume":"4","author":"Y Xu","year":"2022","unstructured":"Xu Y, Huang SW, Ma YQ, Ding HM. Loading of DOX into a tetrahedral DNA nanostructure: the corner does matter. Nanoscale Adv. 2022;4:754\u201360.","journal-title":"Nanoscale Adv"},{"key":"4538_CR122","doi-asserted-by":"publisher","first-page":"135713","DOI":"10.1016\/j.ijbiomac.2024.135713","volume":"280","author":"J Liu","year":"2024","unstructured":"Liu J, Li X, Wu Y, Zhang X, Wang X, Yuan L, Zhao Y, Liu M. A multifunctional DNA tetrahedron for imaging, gene therapy, and chemotherapy-phototherapy combination: Binding affinity and anticancer activity. Int J Biol Macromol. 2024;280:135713.","journal-title":"Int J Biol Macromol"},{"key":"4538_CR123","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.colsurfb.2017.06.014","volume":"157","author":"JH Kang","year":"2017","unstructured":"Kang JH, Kim KR, Lee H, Ahn DR, Ko YT. In vitro and in vivo behavior of DNA tetrahedrons as tumor-targeting nanocarriers for doxorubicin delivery. Colloids Surf B Biointerfaces. 2017;157:424\u201331.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4538_CR124","doi-asserted-by":"publisher","first-page":"122283","DOI":"10.1016\/j.biomaterials.2023.122283","volume":"301","author":"Q Fan","year":"2023","unstructured":"Fan Q, Li Z, Yin J, Xie M, Cui M, Fan C, Wang L, Chao J. Inhalable pH-responsive DNA tetrahedron nanoplatform for boosting anti-tumor immune responses against metastatic lung cancer. Biomaterials. 2023;301:122283.","journal-title":"Biomaterials"},{"key":"4538_CR125","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1186\/s12951-025-03553-1","volume":"23","author":"Y Hu","year":"2025","unstructured":"Hu Y, Chen Z, Mao X, Qu D, Zhai D, Li N, Zhou S, Xue X, Li M. A novel tetrahedral framework nucleic acid-based antibiotic delivery system: overcoming biofilm barriers to combat chronic infections. J Nanobiotechnol. 2025;23:465.","journal-title":"J Nanobiotechnol"},{"key":"4538_CR126","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1021\/jacsau.4c01170","volume":"5","author":"J Gu","year":"2025","unstructured":"Gu J, Liang J, Tian T, Lin Y. Current Understanding and Translational Prospects of Tetrahedral Framework Nucleic Acids. JACS Au. 2025;5:486\u2013520.","journal-title":"JACS Au"},{"key":"4538_CR127","doi-asserted-by":"publisher","first-page":"6726","DOI":"10.1093\/nar\/gku269","volume":"42","author":"KA Wilson","year":"2014","unstructured":"Wilson KA, Kellie JL, Wetmore SD. DNA-protein \u03c0-interactions in nature: abundance, structure, composition and strength of contacts between aromatic amino acids and DNA nucleobases or deoxyribose sugar. Nucleic Acids Res. 2014;42:6726\u201341.","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 1","key":"4538_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2000.10506597","volume":"17","author":"J Sponer","year":"2000","unstructured":"Sponer J, Berger I, Spa\u010dkov\u00e1 N, Leszczynski J, Hobza P. Aromatic Base Stacking in DNA: From ab initio Calculations to Molecular Dynamics Simulations. J Biomol Struct Dyn. 2000;17(Suppl 1):1\u201324.","journal-title":"J Biomol Struct Dyn"},{"key":"4538_CR129","doi-asserted-by":"publisher","first-page":"127947","DOI":"10.1016\/j.ijbiomac.2023.127947","volume":"255","author":"FY Chung","year":"2024","unstructured":"Chung FY, Lin YZ, Huang CR, Huang KW, Chen YF. Crosslinking kiwifruit-derived DNA with natural aromatic aldehydes generates membranolytic antibacterial nanogels. Int J Biol Macromol. 2024;255:127947.","journal-title":"Int J Biol Macromol"},{"key":"4538_CR130","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1021\/nn505825z","volume":"9","author":"CY Li","year":"2015","unstructured":"Li CY, Hemmig EA, Kong J, Yoo J, Hern\u00e1ndez-Ainsa S, Keyser UF, Aksimentiev A. Ionic conductivity, structural deformation, and programmable anisotropy of DNA origami in electric field. ACS Nano. 2015;9:1420\u201333.","journal-title":"ACS Nano"},{"key":"4538_CR131","doi-asserted-by":"publisher","first-page":"e2307809121","DOI":"10.1073\/pnas.2307809121","volume":"121","author":"N Nabar","year":"2024","unstructured":"Nabar N, Dacoba TG, Covarrubias G, Romero-Cruz D, Hammond PT. Electrostatic adsorption of polyanions onto lipid nanoparticles controls uptake, trafficking, and transfection of RNA and DNA therapies. Proc Natl Acad Sci U S A. 2024;121:e2307809121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4538_CR132","doi-asserted-by":"publisher","first-page":"eaau1157","DOI":"10.1126\/sciadv.aau1157","volume":"4","author":"T Gerling","year":"2018","unstructured":"Gerling T, Kube M, Kick B, Dietz H. Sequence-programmable covalent bonding of designed DNA assemblies. Sci Adv. 2018;4:eaau1157.","journal-title":"Sci Adv"},{"key":"4538_CR133","doi-asserted-by":"publisher","first-page":"155937","DOI":"10.1016\/j.phymed.2024.155937","volume":"134","author":"F Yang","year":"2024","unstructured":"Yang F, Zhou H, Luo P, Jia L, Hou M, Huang J, Gao L, Zhang Q, Guan Y, Bao H, et al. Celastrol induces DNA damage and cell death in BCR-ABL T315I-mutant CML by targeting YY1 and HMCES. Phytomedicine. 2024;134:155937.","journal-title":"Phytomedicine"},{"key":"4538_CR134","first-page":"2877","volume":"36","author":"Y Wang","year":"2020","unstructured":"Wang Y. [Interaction between quercetin and DNA]. Sheng Wu Gong Cheng Xue Bao. 2020;36:2877\u201391.","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"key":"4538_CR135","doi-asserted-by":"publisher","first-page":"114068","DOI":"10.1016\/j.ejmech.2021.114068","volume":"229","author":"SR Alizadeh","year":"2022","unstructured":"Alizadeh SR, Ebrahimzadeh MA. Quercetin derivatives: Drug design, development, and biological activities, a review. Eur J Med Chem. 2022;229:114068.","journal-title":"Eur J Med Chem"},{"key":"4538_CR136","doi-asserted-by":"crossref","unstructured":"Boo HJ, Yoon D, Choi Y, Kim Y, Cha JS, Yoo J. Quercetin: Molecular Insights into Its Biological Roles. Biomolecules 2025, 15.","DOI":"10.3390\/biom15030313"},{"key":"4538_CR137","doi-asserted-by":"crossref","unstructured":"Xu D, Hu MJ, Wang YQ, Cui YL. Antioxidant Activities of Quercetin and Its Complexes for Medicinal Application. Molecules 2019;24:1123.","DOI":"10.3390\/molecules24061123"},{"key":"4538_CR138","doi-asserted-by":"crossref","unstructured":"Pan H, Wang Y, Bai X, Liu B, Quan H, Zeng Q, Zeng J, Tang Q, Gu L, Deng Z et al. MiR-145 affects cell cycles by inhibiting cyclin A2 and cyclin dependent kinase 6 in oral squamous cell carcinoma, a progression and prognostic biomarker. Oral Sci Homeost Med 2025;1:9610002.","DOI":"10.26599\/OSHM.2025.9610002"},{"key":"4538_CR139","doi-asserted-by":"crossref","unstructured":"Wang W, Yan R, Lin L, Peng L, Xiong Y, Chen H, Gao X, Liu K, Zhou L, Lin Y. Amelioration of radiation cystitis by tetrahedral framework nucleic acid nanostructures functionalized with quercetin. Chem Eng J 2024;493:152736.","DOI":"10.1016\/j.cej.2024.152736"},{"key":"4538_CR140","doi-asserted-by":"crossref","unstructured":"Cifre M, Palou A, Oliver P. The Metabolically Obese, Normal-Weight Phenotype in Young Rats Is Associated with Cognitive Impairment and Partially Preventable with Leptin Intake during Lactation. Int J Mol Sci 2023;25:228.","DOI":"10.3390\/ijms25010228"},{"key":"4538_CR141","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.bbrc.2018.11.014","volume":"507","author":"W Hong","year":"2018","unstructured":"Hong W, Park J, Yun W, Kang PJ, Son D, Jang J, Kim IY, You S. Inhibitory effect of celastrol on adipogenic differentiation of human adipose-derived stem cells. Biochem Biophys Res Commun. 2018;507:236\u201341.","journal-title":"Biochem Biophys Res Commun"},{"key":"4538_CR142","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.molmet.2016.11.002","volume":"6","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Geng C, Liu X, Li M, Gao M, Liu X, Fang F, Chang Y. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1. Mol Metab. 2017;6:138\u201347.","journal-title":"Mol Metab"},{"key":"4538_CR143","doi-asserted-by":"publisher","first-page":"116099","DOI":"10.1016\/j.taap.2022.116099","volume":"449","author":"MH Abu Bakar","year":"2022","unstructured":"Abu Bakar MH, Nor Shahril NS, Mohamad Khalid MSF, Mohammad S, Shariff KA, Karunakaran T, Mohd Salleh R. ,Mohamad Rosdi MN: Celastrol alleviates high-fat diet-induced obesity via enhanced muscle glucose utilization and mitochondrial oxidative metabolism-mediated upregulation of pyruvate dehydrogenase complex. Toxicol Appl Pharmacol. 2022;449:116099.","journal-title":"Toxicol Appl Pharmacol"},{"key":"4538_CR144","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1039\/D1BM00639H","volume":"9","author":"L Guo","year":"2021","unstructured":"Guo L, Zhang Y, Al-Jamal KT. Recent progress in nanotechnology-based drug carriers for celastrol delivery. Biomater Sci. 2021;9:6355\u201380.","journal-title":"Biomater Sci"},{"key":"4538_CR145","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","volume":"55","author":"TV Rohm","year":"2022","unstructured":"Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55:31\u201355.","journal-title":"Immunity"},{"key":"4538_CR146","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cmet.2008.12.004","volume":"9","author":"L Ozcan","year":"2009","unstructured":"Ozcan L, Ergin AS, Lu A, Chung J, Sarkar S, Nie D, Myers MG. Jr.,Ozcan U: Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 2009;9:35\u201351.","journal-title":"Cell Metab"},{"key":"4538_CR147","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1038\/s41467-023-37169-6","volume":"14","author":"RA Saxton","year":"2023","unstructured":"Saxton RA, Caveney NA, Moya-Garzon MD, Householder KD, Rodriguez GE, Burdsall KA, Long JZ. Garcia KC: Structural insights into the mechanism of leptin receptor activation. Nat Commun. 2023;14:1797.","journal-title":"Nat Commun"},{"key":"4538_CR148","doi-asserted-by":"publisher","first-page":"115621","DOI":"10.1016\/j.biopha.2023.115621","volume":"167","author":"J Liu","year":"2023","unstructured":"Liu J, Huang J, Gong B, Cheng S, Liu Y, Chen Y, Feng Q, Li J, Qiu M, Yu G, Liao Y. Polydatin protects against calcium oxalate crystal-induced renal injury through the cytoplasmic\/mitochondrial reactive oxygen species-NLRP3 inflammasome pathway. Biomed Pharmacother. 2023;167:115621.","journal-title":"Biomed Pharmacother"},{"key":"4538_CR149","doi-asserted-by":"crossref","unstructured":"Chimento A, De Amicis F, Sirianni R, Sinicropi MS, Puoci F, Casaburi I, Saturnino C. Pezzi V: Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol. Int J Mol Sci 2019;20:1381.","DOI":"10.3390\/ijms20061381"},{"key":"4538_CR150","doi-asserted-by":"crossref","unstructured":"Feng S, Yan R, Tang C, Yin Z, Liu B, Chen P, He Y, Zhou L, Lin Y. Modulating ferroptosis for the prevention of urinary stone recurrence: An innovative strategy employing Tetrahedral Framework Nucleic acids and Polydatin conjugates. Chem Eng J 2024;496:153655.","DOI":"10.1016\/j.cej.2024.153655"},{"key":"4538_CR151","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3109\/02652048.2012.668955","volume":"29","author":"K Deshmukh","year":"2012","unstructured":"Deshmukh K, Poddar SS. Tyrosinase inhibitor-loaded microsponge drug delivery system: new approach for hyperpigmentation disorders. J Microencapsul. 2012;29:559\u201368.","journal-title":"J Microencapsul"},{"key":"4538_CR152","doi-asserted-by":"publisher","first-page":"e13495","DOI":"10.1111\/cpr.13495","volume":"56","author":"J He","year":"2023","unstructured":"He J, Chen W, Chen X, Xie Y, Zhao Y, Tian T, Guo B, Cai X. Tetrahedral framework nucleic acid loaded with glabridin: A transdermal delivery system applicated to anti-hyperpigmentation. Cell Prolif. 2023;56:e13495.","journal-title":"Cell Prolif"},{"key":"4538_CR153","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41413-024-00319-7","volume":"12","author":"Y Li","year":"2024","unstructured":"Li Y, Cai Z, Ma W, Bai L, Luo E, Lin Y. A DNA tetrahedron-based ferroptosis-suppressing nanoparticle: superior delivery of curcumin and alleviation of diabetic osteoporosis. Bone Res. 2024;12:14.","journal-title":"Bone Res"},{"key":"4538_CR154","doi-asserted-by":"publisher","first-page":"7745","DOI":"10.1002\/anie.201403236","volume":"53","author":"L Liang","year":"2014","unstructured":"Liang L, Li J, Li Q, Huang Q, Shi J, Yan H, Fan C. Single-particle tracking and modulation of cell entry pathways of a tetrahedral DNA nanostructure in live cells. Angew Chem Int Ed Engl. 2014;53:7745\u201350.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4538_CR155","doi-asserted-by":"publisher","first-page":"e2411770","DOI":"10.1002\/advs.202411770","volume":"12","author":"H Xu","year":"2025","unstructured":"Xu H, Feng R, Ye ML, Hu JC, Lu JY, Wang JY, Zuo HT, Zhao Y, Song JY, Jiang JD, et al. Multiple Enzymes Expressed by the Gut Microbiota Can Transform Typhaneoside and Are Associated with Improving Hyperlipidemia. Adv Sci (Weinh). 2025;12:e2411770.","journal-title":"Adv Sci (Weinh)"},{"key":"4538_CR156","doi-asserted-by":"publisher","first-page":"114079","DOI":"10.1016\/j.bcp.2020.114079","volume":"180","author":"F Dou","year":"2020","unstructured":"Dou F, Ding Y, Wang C, Duan J, Wang W, Xu H, Zhao X, Wang J, Wen A. Chrysophanol ameliorates renal interstitial fibrosis by inhibiting the TGF-\u03b2\/Smad signaling pathway. Biochem Pharmacol. 2020;180:114079.","journal-title":"Biochem Pharmacol"},{"key":"4538_CR157","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/02652048.2020.1849440","volume":"38","author":"M Gu","year":"2021","unstructured":"Gu M, Lu L, Wei Q, Miao Z, Zhang H, Gao L, Li L. Improved oral bioavailability and anti-chronic renal failure activity of chrysophanol via mixed polymeric micelles. J Microencapsul. 2021;38:47\u201360.","journal-title":"J Microencapsul"},{"key":"4538_CR158","doi-asserted-by":"publisher","first-page":"107032","DOI":"10.1016\/j.phrs.2023.107032","volume":"199","author":"R Wang","year":"2024","unstructured":"Wang R, Wang C, Lu L, Yuan F, He F. Baicalin and baicalein in modulating tumor microenvironment for cancer treatment: A comprehensive review with future perspectives. Pharmacol Res. 2024;199:107032.","journal-title":"Pharmacol Res"},{"key":"4538_CR159","doi-asserted-by":"crossref","unstructured":"Gao X, Xiao D, Wang W, Peng L, Li F, He Y, Wei X, Lin Y. Tetrahedral framework nucleic acids loaded with chrysophanol for the treatment of chronic kidney disease. Chem Eng J 2025;516:164174.","DOI":"10.1016\/j.cej.2025.164174"},{"key":"4538_CR160","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1021\/acsnano.4c12917","volume":"19","author":"M Zhou","year":"2025","unstructured":"Zhou M, Tang Y, Lu Y, Zhang T, Zhang S, Cai X, Lin Y. Framework Nucleic Acid-Based and Neutrophil-Based Nanoplatform Loading Baicalin with Targeted Drug Delivery for Anti-Inflammation Treatment. ACS Nano. 2025;19:3455\u201369.","journal-title":"ACS Nano"},{"key":"4538_CR161","doi-asserted-by":"crossref","unstructured":"Yao Y, Lei X, Li X, Ge Y, Wang Y, Qin X, Gao Y, Zhang G, Lin Y, Gao S. Cai X: A trackable mitochondria-targeting nanosystem for mitochondrial redox and mitophagy regulation in diabetic retinopathy management. Chem Eng J 2025;505:159618.","DOI":"10.1016\/j.cej.2025.159618"},{"key":"4538_CR162","doi-asserted-by":"publisher","first-page":"e2502661","DOI":"10.1002\/advs.202502661","volume":"12","author":"K Huang","year":"2025","unstructured":"Huang K, Li Q, Lin H, Shen Q, Wu Y, Tian T, Ma C, Shi S, Xiao J, Lin Y. Cartilage-Penetrating Framework Nucleic Acid Nanoparticles Ameliorate Osteoarthritis by Promoting Drug Delivery and Chondrocyte Uptake. Adv Sci (Weinh). 2025;12:e2502661.","journal-title":"Adv Sci (Weinh)"},{"key":"4538_CR163","doi-asserted-by":"crossref","unstructured":"Li Y, Li J, Chang Y, Zhang J, Wang Z, Wang F, Lin Y, Sui L. Mitochondria-targeted drug delivery system based on tetrahedral framework nucleic acids for bone regeneration under oxidative stress. Chem Eng J 2024;496:153723.","DOI":"10.1016\/j.cej.2024.153723"},{"key":"4538_CR164","doi-asserted-by":"publisher","first-page":"e2303706","DOI":"10.1002\/advs.202303706","volume":"10","author":"M Zhang","year":"2023","unstructured":"Zhang M, Qin X, Gao Y, Liang J, Xiao D, Zhang X, Zhou M, Lin Y. Transcutaneous Immunotherapy for RNAi: A Cascade-Responsive Decomposable Nanocomplex Based on Polyphenol-Mediated Framework Nucleic Acid in Psoriasis. Adv Sci (Weinh). 2023;10:e2303706.","journal-title":"Adv Sci (Weinh)"},{"key":"4538_CR165","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s13318-018-0509-3","volume":"44","author":"T Huang","year":"2019","unstructured":"Huang T, Liu Y, Zhang C. Pharmacokinetics and Bioavailability Enhancement of Baicalin: A Review. Eur J Drug Metab Pharmacokinet. 2019;44:159\u201368.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"4538_CR166","doi-asserted-by":"crossref","unstructured":"Wen Y, Wang Y, Zhao C, Zhao B, Wang J. The Pharmacological Efficacy of Baicalin in Inflammatory Diseases. Int J Mol Sci 2023;24:9317.","DOI":"10.3390\/ijms24119317"},{"key":"4538_CR167","doi-asserted-by":"publisher","first-page":"112164","DOI":"10.1016\/j.biopha.2021.112164","volume":"143","author":"LX Zhang","year":"2021","unstructured":"Zhang LX, Li CX, Kakar MU, Khan MS, Wu PF, Amir RM, Dai DF, Naveed M, Li QY, Saeed M, et al. Resveratrol (RV): A pharmacological review and call for further research. Biomed Pharmacother. 2021;143:112164.","journal-title":"Biomed Pharmacother"},{"key":"4538_CR168","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.001","volume":"515","author":"B Ren","year":"2021","unstructured":"Ren B, Kwah MX, Liu C, Ma Z, Shanmugam MK, Ding L, Xiang X, Ho PC, Wang L, Ong PS. Goh BC: Resveratrol for cancer therapy: Challenges and future perspectives. Cancer Lett. 2021;515:63\u201372.","journal-title":"Cancer Lett"},{"key":"4538_CR169","doi-asserted-by":"crossref","unstructured":"Breuss JM, Atanasov AG, Uhrin P. Resveratrol and Its Effects on the Vascular System. Int J Mol Sci 2019;20:1523.","DOI":"10.3390\/ijms20071523"},{"key":"4538_CR170","doi-asserted-by":"publisher","first-page":"102363","DOI":"10.1016\/j.redox.2022.102363","volume":"54","author":"XC Ni","year":"2022","unstructured":"Ni XC, Wang HF, Cai YY, Yang D, Alolga RN, Liu B, Li J, Huang FQ. Ginsenoside Rb1 inhibits astrocyte activation and promotes transfer of astrocytic mitochondria to neurons against ischemic stroke. Redox Biol. 2022;54:102363.","journal-title":"Redox Biol"},{"key":"4538_CR171","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1142\/S0192415X21500907","volume":"49","author":"GW Qin","year":"2021","unstructured":"Qin GW, Lu P, Peng L, Jiang W. Ginsenoside Rb1 Inhibits Cardiomyocyte Autophagy via PI3K\/Akt\/mTOR Signaling Pathway and Reduces Myocardial Ischemia\/Reperfusion Injury. Am J Chin Med. 2021;49:1913\u201327.","journal-title":"Am J Chin Med"},{"key":"4538_CR172","doi-asserted-by":"crossref","unstructured":"Zhou P, Xie W, He S, Sun Y, Meng X, Sun G, Sun X. Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis. Cells 2019, 8.","DOI":"10.3390\/cells8030204"},{"key":"4538_CR173","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.2174\/1871520623666230119092735","volume":"23","author":"L Wang","year":"2023","unstructured":"Wang L, Zhang QQ, Xu YY, Zhang R, Zhao Q, Zhang YQ, Huang XH, Jiang B, Ni M. Ginsenoside Rb1 Suppresses AOM\/DSS-induced Colon Carcinogenesis. Anticancer Agents Med Chem. 2023;23:1067\u201373.","journal-title":"Anticancer Agents Med Chem"},{"key":"4538_CR174","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mcp.2018.12.001","volume":"43","author":"P Zhou","year":"2019","unstructured":"Zhou P, Xie W, Sun Y, Dai Z, Li G, Sun G, Sun X. Ginsenoside Rb1 and mitochondria: A short review of the literature. Mol Cell Probes. 2019;43:1\u20135.","journal-title":"Mol Cell Probes"},{"key":"4538_CR175","doi-asserted-by":"publisher","first-page":"338","DOI":"10.2174\/1389200224666230202155414","volume":"24","author":"Y Yao","year":"2023","unstructured":"Yao Y, Yang M, Shi S. Nucleic Acid Nanomaterials-based Therapy for Osteoarthritis: Progress and Prospects. Curr Drug Metab. 2023;24:338\u201352.","journal-title":"Curr Drug Metab"},{"key":"4538_CR176","doi-asserted-by":"crossref","unstructured":"Liu X, Han J, Chen Y, Hu J, Liu Y. The radiographic measurement for infrabony defects by CBCT in periodontal regeneration: technical report. Oral Science and Homeostatic Medicine 2025, 1.","DOI":"10.26599\/OSHM.2025.9610019"},{"key":"4538_CR177","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1177\/0960327119864154","volume":"38","author":"A Soyocak","year":"2019","unstructured":"Soyocak A, Kurt H, Cosan DT, Saydam F, Calis IU, Kolac UK, Koroglu ZO, Degirmenci I, Mutlu FS, Gunes HV. Tannic acid exhibits anti-inflammatory effects on formalin-induced paw edema model of inflammation in rats. Hum Exp Toxicol. 2019;38:1296\u2013301.","journal-title":"Hum Exp Toxicol"},{"key":"4538_CR178","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.cyto.2015.05.016","volume":"76","author":"V Karuppagounder","year":"2015","unstructured":"Karuppagounder V, Arumugam S, Thandavarayan RA, Pitchaimani V, Sreedhar R, Afrin R, Harima M, Suzuki H, Nomoto M, Miyashita S, et al. Tannic acid modulates NF\u03baB signaling pathway and skin inflammation in NC\/Nga mice through PPAR\u03b3 expression. Cytokine. 2015;76:206\u201313.","journal-title":"Cytokine"},{"key":"4538_CR179","doi-asserted-by":"crossref","unstructured":"Huang J, Xiao K. Nanoparticles-Based Strategies to Improve the Delivery of Therapeutic Small Interfering RNA in Precision Oncology. Pharmaceutics; 2022. p. 14.","DOI":"10.3390\/pharmaceutics14081586"},{"key":"4538_CR180","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/1389200224666230601091346","volume":"24","author":"X Xie","year":"2023","unstructured":"Xie X, Ma W, Zhan Y, Zhang Q, Wang C, Zhu H. Methods to Improve the Stability of Nucleic Acid-Based Nanomaterials. Curr Drug Metab. 2023;24:315\u201326.","journal-title":"Curr Drug Metab"},{"key":"4538_CR181","first-page":"523","volume":"17","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhao Z, Li M. Overcoming the cellular barriers and beyond: Recent progress on cell penetrating peptide modified nanomedicine in combating physiological and pathological barriers. Asian J Pharm Sci. 2022;17:523\u201343.","journal-title":"Asian J Pharm Sci"},{"key":"4538_CR182","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2174\/1389200224666230614115655","volume":"24","author":"L Yao","year":"2023","unstructured":"Yao L, Hai Q, Zhang T. The Application of Nucleic Acid Nanomaterials in the Treatment of Mitochondrial Dysfunction. Curr Drug Metab. 2023;24:393\u2013403.","journal-title":"Curr Drug Metab"},{"key":"4538_CR183","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.apsb.2021.03.013","volume":"11","author":"Q Wang","year":"2021","unstructured":"Wang Q, Qin X, Fang J, Sun X. Nanomedicines for the treatment of rheumatoid arthritis: State of art and potential therapeutic strategies. Acta Pharm Sin B. 2021;11:1158\u201374.","journal-title":"Acta Pharm Sin B"},{"key":"4538_CR184","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1080\/17425247.2023.2276285","volume":"20","author":"J Li","year":"2023","unstructured":"Li J, Yan R, Shi S, Lin Y. Recent progress and application of the tetrahedral framework nucleic acid materials on drug delivery. Expert Opin Drug Deliv. 2023;20:1511\u201330.","journal-title":"Expert Opin Drug Deliv"},{"key":"4538_CR185","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jconrel.2020.11.050","volume":"329","author":"J Yan","year":"2021","unstructured":"Yan J, Zhang N, Zhang Z, Zhu W, Li B, Li L, Pu Y, He B. Redox-responsive polyethyleneimine\/tetrahedron DNA\/doxorubicin nanocomplexes for deep cell\/tissue penetration to overcome multidrug resistance. J Control Release. 2021;329:36\u201349.","journal-title":"J Control Release"},{"key":"4538_CR186","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.addr.2017.10.001","volume":"124","author":"L Wu","year":"2018","unstructured":"Wu L, Shan W, Zhang Z, Huang Y. Engineering nanomaterials to overcome the mucosal barrier by modulating surface properties. Adv Drug Deliv Rev. 2018;124:150\u201363.","journal-title":"Adv Drug Deliv Rev"},{"key":"4538_CR187","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2174\/1389200217666160714095722","volume":"17","author":"X Zhou","year":"2016","unstructured":"Zhou X, Liu R, Qin S, Yu R, Fu Y. Current Status and Future Directions of Nanoparticulate Strategy for Cancer Immunotherapy. Curr Drug Metab. 2016;17:755\u201362.","journal-title":"Curr Drug Metab"},{"key":"4538_CR188","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.drudis.2020.11.006","volume":"26","author":"B Chen","year":"2021","unstructured":"Chen B, Mei L, Wang Y, Guo G. Advances in intelligent DNA nanomachines for targeted cancer therapy. Drug Discov Today. 2021;26:1018\u201329.","journal-title":"Drug Discov Today"},{"key":"4538_CR189","doi-asserted-by":"crossref","unstructured":"Wu P, Han J, Gong Y, Liu C, Yu H, Xie N. Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications. Pharmaceutics 2022;14:1990.","DOI":"10.3390\/pharmaceutics14101990"},{"key":"4538_CR190","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.phrs.2017.05.004","volume":"126","author":"S Yang","year":"2017","unstructured":"Yang S, Gao H. Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy. Pharmacol Res. 2017;126:97\u2013108.","journal-title":"Pharmacol Res"},{"key":"4538_CR191","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.apsb.2016.05.013","volume":"6","author":"H Gao","year":"2016","unstructured":"Gao H. Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharm Sin B. 2016;6:268\u201386.","journal-title":"Acta Pharm Sin B"},{"key":"4538_CR192","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.addr.2020.06.030","volume":"167","author":"J Cao","year":"2020","unstructured":"Cao J, Huang D, Peppas NA. Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites. Adv Drug Deliv Rev. 2020;167:170\u201388.","journal-title":"Adv Drug Deliv Rev"},{"key":"4538_CR193","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1016\/j.apsb.2024.06.015","volume":"14","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Luo S, Xu M, He Q, Xie J, Wu J, Huang Y. Transepithelial transport of nanoparticles in oral drug delivery: From the perspective of surface and holistic property modulation. Acta Pharm Sin B. 2024;14:3876\u2013900.","journal-title":"Acta Pharm Sin B"},{"key":"4538_CR194","doi-asserted-by":"publisher","first-page":"115239","DOI":"10.1016\/j.addr.2024.115239","volume":"207","author":"J Liu","year":"2024","unstructured":"Liu J, Cabral H, Mi P. Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release. Adv Drug Deliv Rev. 2024;207:115239.","journal-title":"Adv Drug Deliv Rev"},{"key":"4538_CR195","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1021\/la0472302","volume":"21","author":"CY Lee","year":"2005","unstructured":"Lee CY, Canavan HE, Gamble LJ, Castner DG. Evidence of impurities in thiolated single-stranded DNA oligomers and their effect on DNA self-assembly on gold. Langmuir. 2005;21:5134\u201341.","journal-title":"Langmuir"},{"key":"4538_CR196","doi-asserted-by":"publisher","first-page":"8365","DOI":"10.1021\/acs.langmuir.3c03778","volume":"40","author":"A Ebrahimimojarad","year":"2024","unstructured":"Ebrahimimojarad A, Wang Z, Zhang Q, Shah A, Brenner JS, Fu J. A Robust and Efficient Method to Purify DNA-Scaffolded Nanostructures by Gravity-Driven Size Exclusion Chromatography. Langmuir. 2024;40:8365\u201372.","journal-title":"Langmuir"},{"key":"4538_CR197","doi-asserted-by":"crossref","unstructured":"Hu Y, Chen Z, Hou Z, Li M, Ma B, Luo X, Xue X. Influence of Magnesium Ions on the Preparation and Storage of DNA Tetrahedrons in Micromolar Ranges. Molecules 2019;24:2091.","DOI":"10.3390\/molecules24112091"},{"key":"4538_CR198","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/s41565-024-01754-7","volume":"19","author":"P Joyce","year":"2024","unstructured":"Joyce P, Allen CJ, Alonso MJ, Ashford M, Bradbury MS, Germain M, Kavallaris M, Langer R, Lammers T, Peracchia MT, et al. A translational framework to DELIVER nanomedicines to the clinic. Nat Nanotechnol. 2024;19:1597\u2013611.","journal-title":"Nat Nanotechnol"},{"key":"4538_CR199","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nbt.1504","volume":"26","author":"MR Prausnitz","year":"2008","unstructured":"Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26:1261\u20138.","journal-title":"Nat Biotechnol"},{"key":"4538_CR200","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12951-021-01164-0","volume":"19","author":"J Yan","year":"2021","unstructured":"Yan J, Zhan X, Zhang Z, Chen K, Wang M, Sun Y, He B, Liang Y. Tetrahedral DNA nanostructures for effective treatment of cancer: advances and prospects. J Nanobiotechnol. 2021;19:412.","journal-title":"J Nanobiotechnol"},{"key":"4538_CR201","doi-asserted-by":"publisher","first-page":"113982","DOI":"10.1016\/j.colsurfb.2024.113982","volume":"240","author":"M Hu","year":"2024","unstructured":"Hu M, Yingyu Z, Zhang M, Wang Q, Cheng W, Hou L, Yuan J, Yu Z, Li L, Zhang X, Zhang W. Functionalizing tetrahedral framework nucleic acids-based nanostructures for tumor in situ imaging and treatment. Colloids Surf B Biointerfaces. 2024;240:113982.","journal-title":"Colloids Surf B Biointerfaces"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04538-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04538-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04538-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:02:50Z","timestamp":1783699370000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04538-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":201,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4538"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04538-4","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors declare full consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"638"}}